| Thailandia | Turchia | Austria | |
| Tomoterapia | da $30,000 / 1,020,000฿ | da $12,000 / 408,000฿ | da $30,000 / 1,020,000฿ |
| Terapia con protoni | da $90,000 / 3,060,000฿ | da $70,000 / 2,380,000฿ | da $80,000 / 2,720,000฿ |
| CyberKnife | da $30,000 / 1,020,000฿ | da $4,750 / 161,500฿ | da $50,000 / 1,700,000฿ |
| Criodistruzione | da $3,000 / 102,000฿ | da $3,500 / 119,000฿ | da $4,000 / 136,000฿ |
| Chemoembolizzazione del fegato | da $7,500 / 255,000฿ | da $7,500 / 255,000฿ | da $16,000 / 544,000฿ |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore epatico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore epatico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore epatico.
Il dott. Asawadech Sanbua è specializzato nel trattamento del cancro al fegato con 18 anni di esperienza, incluse oltre 900 procedure presso il Panacee Hospital Rama2.
Il medico è un chirurgo con specializzazione in oncochirurgia, focalizzato sul trattamento del tratto gastrointestinale. Con una vasta esperienza in oncologia chirurgica, il medico è dedicato ad avanzare le tecniche e migliorare i risultati dei pazienti nelle chirurgie gastrointestinali.<\/p>
Primary liver cancer treatments in Thailand include surgical resection, radiofrequency ablation, and chemoembolization. High-volume centers in Bangkok also offer advanced radiation therapies like Proton-beam therapy and CyberKnife. These facilities maintain high standards through JCI accreditation and international quality management certifications.
Bookimed Expert Insight: While many seek surgery, Thailand’s strength lies in combining traditional oncology with cellular therapy. Panacee Hospital Rama 2 serves 1,000 patients yearly using integrative methods like oncothermia. This holistic approach focuses on cellular rejuvenation alongside standard tumor treatments.
Patient Consensus: Patients value the balance between specialized medical care and wellness support. Many emphasize that having access to both advanced radiation and traditional detoxification helps them manage side effects better.
Thailand offers advanced immunotherapy, including FDA-approved checkpoint inhibitors and cellular therapies, at major JCI-accredited hospitals. Specialized methods like CAR T-cell therapy and personalized vaccines are available in Bangkok. These treatments are often 30% to 70% more cost-effective than in Western countries.
Bookimed Expert Insight: While many seeking immunotherapy focus on drug availability, the real advantage in Thailand is the specialized infrastructure for integrative oncology. For example, Dr. asawadech Sanbua at Panacee Hospital Rama 2 has over 5 years of expertise specifically combining immunotherapy with oncothermia machines. This synergy is rare in standard Western oncology but is a hallmark of Thai private centers.
Patient Consensus: Patients note that immunotherapy is significantly more affordable in Thailand, but emphasize that long-term monitoring requires careful coordination with doctors back home. Many recommend sending pathology reports early to confirm if specific drugs like Nivolumab are suitable for their case.
Thailand leading hospitals for liver cancer include Bumrungrad International and Bangkok Hospital Pattaya. These facilities hold Joint Commission International accreditation for oncology safety. Surgeons utilize robotic-assisted systems and proton therapy to treat complex tumors. Specialized centers in Bangkok offer multidisciplinary care with high survival rates.
Bookimed Expert Insight: Data shows a clear distinction between Bangkok massive multi-specialty hubs and specialized integrative centers. Bumrungrad treats 1,000,000 patients annually with heavy emphasis on robotic surgery. Meanwhile, Panacee Hospital focuses on a boutique approach with only 40 beds. This allows for highly personalized cell-based therapies that larger institutions may not prioritize.
International patients can undergo liver transplants in Thailand through living donor programs at accredited private hospitals. Deceased donor organs are reserved for Thai citizens. International candidates must bring a compatible blood or genetic relative as a donor. Documentation must prove a legal relationship.
Bookimed Expert Insight: Thai medical centers like Bumrungrad International Hospital serve over 1,000,000 patients annually. This high volume supports specialized teams for complex gastrointestinal oncology. Dr. Yongyut Sirivatanauksorn at Bumrungrad focuses specifically on gastrointestinal tract surgeries. Choosing centers with huge patient volumes often ensures better access to dedicated transplant coordination teams. These teams manage the intensive legal and medical documentation international patients require.
Patient Consensus: Patients emphasize that you cannot simply book a transplant online without an in-person evaluation. It is vital to secure a long-term follow-up plan for anti-rejection medications in your home country first.
Success rates for liver cancer treatment in Thailand vary by stage and chosen method. Early-stage patients achieve high success through surgical resection or specialized ablation. JCI-accredited centers utilize advanced imaging and multidisciplinary teams to ensure precise tumor targeting and improved health outcomes.
Bookimed Expert Insight: Thailand attracts 1 million patients annually to facilities like Bumrungrad International Hospital due to its massive scale and technology. Specialists there, such as Dr. Yongyut Sirivatanauksorn, focus on oncosurgery, which remains a primary tool for curative intent. Patients should note that high-volume centers often offer broader diagnostic tools like PET-CT and histopathology revision to refine treatment plans.